| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-04-10 | Knight Jeff E. Chief Dev. & Operating Officer | Sale | -85,163 | -44.72%105,289 | $40.10 | $3,415,036 | View SEC filing | |
| 2026-03-18 | Knight Jeff E. Chief Operating Officer | Sale | -9,911 | -8.13%112,018 | $37.37 | $370,411 | View SEC filing | |
| 2026-03-18 | Betz Stephen F. Chief Scientific Officer | Sale | -10,612 | -7.18%137,101 | $37.37 | $396,610 | View SEC filing | |
| 2026-03-18 | Struthers Richard Scott President & CEO | Sale | -21,981 | -5.15%404,778 | $37.37 | $821,513 | View SEC filing | |
| 2026-03-13 | Vivaldi Coelho Rogerio Director | Sale | -5,000 | -23.47%16,300 | $36.15 | $180,761 | View SEC filing | |
| 2026-03-04 | Okey Stephanie Director | Sale | -3,000 | -18.40%13,300 | $39.67 | $119,010 | View SEC filing | |
| 2026-03-04 | Schilke Tobin Chief Financial Officer | Sale | -6,713 | -7.91%78,121 | $39.67 | $266,305 | View SEC filing | |
| 2026-01-07 | Kalofonos Isabel Chief Commercial Officer | Sale | -2,500 | -74.99%834 | $55.00 | $137,500 | View SEC filing | |
| 2025-12-03 | Pizzuti Dana Chief Med and Dev Officer | Sale | -5,000 | -6.96%66,837 | $45.02 | $225,100 | View SEC filing | |
| 2025-11-05 | Pizzuti Dana Chief Med and Dev Officer | Sale | -5,000 | -7.02%66,270 | $42.66 | $213,312 | View SEC filing | |
| 2025-10-03 | Pizzuti Dana Chief Med and Dev Officer | Sale | -5,000 | -7.02%66,270 | $41.81 | $209,050 | View SEC filing | |
| 2025-09-30 | Struthers Richard Scott President & CEO | Sale | -4,000 | -3.64%106,000 | $45.00 | $180,000 | View SEC filing | |
| 2025-09-30 | Fust Matthew K Director | Sale | -16,000 | -41.20%22,836 | $44.75 | $716,000 | View SEC filing | |
| 2025-09-04 | Pizzuti Dana Chief Med and Dev Officer | Sale | -5,000 | -4.94%96,270 | $32.10 | $160,500 | View SEC filing | |
| 2025-08-26 | Pizzuti Dana Chief Med and Dev Officer | Sale | -30,000 | -31.16%66,270 | $30.43 | $912,900 | View SEC filing | |
| 2025-08-21 | Pizzuti Dana Chief Med and Dev Officer | Sale | -6,492 | -8.92%66,270 | $29.18 | $189,437 | View SEC filing | |
| 2025-06-16 | Betz Stephen F. Chief Scientific Officer | Sale | -97,483 | -49.43%99,713 | $32.23 | $3,141,877 | View SEC filing | |
| 2025-03-21 | Pizzuti Dana Chief Med and Dev Officer | Sale | -2,515 | -3.36%72,233 | $34.20 | $86,021 | View SEC filing | |
| 2025-03-21 | Knight Jeff E. Chief Operating Officer | Sale | -7,162 | -7.57%87,491 | $34.20 | $244,964 | View SEC filing | |
| 2025-03-21 | Betz Stephen F. Chief Scientific Officer | Sale | -5,770 | -5.05%108,588 | $34.20 | $197,353 | View SEC filing | |
| 2025-03-21 | Struthers Richard Scott President & CEO | Sale | -17,338 | -5.00%329,147 | $34.20 | $593,017 | View SEC filing | |
| 2025-02-05 | Pizzuti Dana Chief Med and Dev Officer | Sale | -5,000 | -13.61%31,748 | $39.07 | $195,350 | View SEC filing | |
| 2025-01-07 | Pizzuti Dana Chief Med and Dev Officer | Sale | -15,000 | -33.90%29,248 | $52.09 | $781,350 | View SEC filing | |
| 2024-12-04 | Struthers Richard Scott President & CEO | Sale | -10,000 | -9.09%100,000 | $57.57 | $575,700 | View SEC filing | |
| 2024-11-26 | Knight Jeff E. Chief Operating Officer | Sale | -501 | -0.96%51,653 | $56.52 | $28,317 | View SEC filing |
1-25 of 135
